A Phase IIa, Multi-center, Randomized, Double-bind, Double-dummy, Active and Placebo Controlled, Parallel Group Study to Assess the Efficacy and Safety of AZD7268 in Patients With Major Depressive Disorder.

Trial Profile

A Phase IIa, Multi-center, Randomized, Double-bind, Double-dummy, Active and Placebo Controlled, Parallel Group Study to Assess the Efficacy and Safety of AZD7268 in Patients With Major Depressive Disorder.

Completed
Phase of Trial: Phase II

Latest Information Update: 09 Apr 2012

At a glance

  • Drugs AZD 7268; Escitalopram
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Apr 2012 Actual patient number changed from 231 to 247 as reported by ClinicalTrials.gov.
    • 08 May 2010 Actual patient number (231) added as reported by ClinicalTrials.gov.
    • 08 May 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top